Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.34    -0.11 (-2.47%)
Bid:
4.31
Ask:
4.355
Spread: 0.045 (1.044%)
Market Cap: £208.30m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Bipartisan Senate legislation

11 Aug 2021 07:00

RNS Number : 2747I
Seeing Machines Limited
11 August 2021
 

 

RNS Reach

 

11 August 2021

 

Seeing Machines Limited

 

Bipartisan Senate legislation includes lifesaving automotive technology provisions

 

New agreement would require Driver Monitoring Systems to stop distracted and drunk driving

 

Canberra, Australia - Today the U.S. Senate passed a bipartisan infrastructure agreement which contains key provisions to improve automotive safety. Specifically, the legislation includes the SAFE Act, introduced by Senators Markey, Blumenthal, and Klobuchar, which would require Driver Monitoring Systems (DMS) to detect distracted driving.

 

In addition, the legislation includes the RIDE Act, which was sponsored by Senators Rick Scott and Ben Ray Lujan which would require new cars to use advanced drunk driving technology to stop impaired driving.

 

"DMS is on the road today in systems like General Motor's Super Cruise™ and can tell whether the driver is engaged in the driving task or is distracted," said Seeing Machines CEO Paul McGlone. "If the driver is distracted, driver monitoring systems have the ability to warn the driver and save lives."

 

The safety provisions would require the National Highway Traffic Administration (NHTSA) to carefully research DMS systems and begin the rulemaking process to regulate this technology. 

 

This legislation comes at a critical time in the United States. Early estimates from NHTSA point to a 9% increase in traffic deaths in 2020. In 2019, 3,142 people were killed due to distracted driving, 10,142 people died by alcohol impaired driving, and 697 people were killed by drowsy driving. DMS has the potential to reduce or eliminate all of these crashes. 

 

"Seeing Machines is pleased to see this progress on automotive safety," said McGlone. "We look forward to continuing to work with the U.S. Congress and NHTSA to ensure these technologies are available to all drivers and save the maximum number of lives."

 

 

 

Media enquiries:

 

Seeing Machines Limited

+61 2 6103 4700

Paul McGlone - CEO

Sophie Nicoll - Corporate Communications

 

 

Lionsgate Communications (Media Enquiries)

Jonathan Charles

+44 7791 892509

 

 

 

About Seeing Machines (LSE: SEE), a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines' technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical.

 

www.seeingmachines.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPUACRUPGUAG
Date   Source Headline
18th Sep 20069:45 amRNSGlaucoma Grant Signed
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.